Stratipath
@stratipath.bsky.social
Stratipath is a spin-out from Karolinska Institutet in Stockholm, Sweden, bringing pioneering research from the fields of artificial intelligence and precision cancer diagnostics into clinical use.
Pinned
Stratipath
@stratipath.bsky.social
· Jun 13
Stratipath Breast is the first CE-IVD, AI-based prognostic risk profiling tool. It analyses cancer tissue, enabling the identification of either an increased or a low risk of disease progression. It is in clinical use and validated in large-scale studies. www.stratipath.com/stratipath-b...
Stratipath’s Chief Medical Officer, Professor Johan Hartman, will be in Visby during Almedalen Policy Week to contribute to key discussions on AI, healthcare innovation, and precision diagnostics. If you would like to connect or involve Johan in a conversation, don’t hesitate to reach out.
June 23, 2025 at 7:27 AM
Stratipath’s Chief Medical Officer, Professor Johan Hartman, will be in Visby during Almedalen Policy Week to contribute to key discussions on AI, healthcare innovation, and precision diagnostics. If you would like to connect or involve Johan in a conversation, don’t hesitate to reach out.
Linköping University Hospital and Region Östergötland have chosen to implement AI-based Stratipath Breast as part of their clinical routine for breast cancer diagnostics.
“We have high expectations for what it could bring to our clinical workflow.” / Pathologist
www.stratipath.com/ostergotland...
“We have high expectations for what it could bring to our clinical workflow.” / Pathologist
www.stratipath.com/ostergotland...
Region Östergötland Implements AI-Powered Stratipath Breast to Enhance Breast Cancer Diagnostics – Stratipath
Linköping University Hospital and Region Östergötland have chosen to implement Stratipath Breast as part of their clinical routine for early breast cancer diagnostics.
www.stratipath.com
June 17, 2025 at 9:18 AM
Linköping University Hospital and Region Östergötland have chosen to implement AI-based Stratipath Breast as part of their clinical routine for breast cancer diagnostics.
“We have high expectations for what it could bring to our clinical workflow.” / Pathologist
www.stratipath.com/ostergotland...
“We have high expectations for what it could bring to our clinical workflow.” / Pathologist
www.stratipath.com/ostergotland...
Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology)
www.stratipath.com/article-in-o...
www.stratipath.com/article-in-o...
Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology) – Stratipath
SwAIPP 2, the continuation of the SwAIPP project, has been funded by Sweden’s innovation agency, Vinnova. We at Stratipath are proud to be partners in this consortium alongside leaders in academia, he...
www.stratipath.com
June 13, 2025 at 9:36 AM
Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology)
www.stratipath.com/article-in-o...
www.stratipath.com/article-in-o...
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast. www.stratipath.com/stratipath-r...
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast – Stratipath
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast. The new capability strengthens clinical decision-making for neoadjuvant therapy.
www.stratipath.com
June 13, 2025 at 9:35 AM
Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast. www.stratipath.com/stratipath-r...
Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göran’s Hospital. www.stratipath.com/unilabs-is-i...
Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göran’s Hospital – Stratipath
Capio St Göran’s Hospital is one of the largest breast cancer clinics in Sweden treating more than 600 breast cancer patients annually. With this new collaboration, Unilabs will use Stratipath Breast ...
www.stratipath.com
June 13, 2025 at 9:35 AM
Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göran’s Hospital. www.stratipath.com/unilabs-is-i...
Stratipath is proud to announce that globally recognized breast oncologist, Professor Daniel F. Hayes, has joined the company’s Scientific Advisory Board. www.stratipath.com/daniel-hayes...
Professor Daniel Hayes Joins Stratipath’s Scientific Advisory Board – Stratipath
Stratipath is proud to announce that globally recognized breast oncologist, Professor Daniel F. Hayes, has joined the company’s Scientific Advisory Board. Professor Hayes will collaborate closely with...
www.stratipath.com
June 13, 2025 at 9:34 AM
Stratipath is proud to announce that globally recognized breast oncologist, Professor Daniel F. Hayes, has joined the company’s Scientific Advisory Board. www.stratipath.com/daniel-hayes...
Region Uppsala, Sweden’s fourth largest healthcare region, has chosen to implement Stratipath Breast, an AI-based risk profiling solution for breast cancer, in clinical use. www.stratipath.com/region-uppsa...
Region Uppsala chooses to implement AI-based risk profiling with Stratipath Breast – Stratipath
Region Uppsala, Sweden’s fourth largest healthcare region, has chosen to implement Stratipath Breast, an AI-based risk profiling solution for breast cancer, in clinical use.
www.stratipath.com
June 13, 2025 at 9:33 AM
Region Uppsala, Sweden’s fourth largest healthcare region, has chosen to implement Stratipath Breast, an AI-based risk profiling solution for breast cancer, in clinical use. www.stratipath.com/region-uppsa...
Stratipath Breast is the first CE-IVD, AI-based prognostic risk profiling tool. It analyses cancer tissue, enabling the identification of either an increased or a low risk of disease progression. It is in clinical use and validated in large-scale studies. www.stratipath.com/stratipath-b...
June 13, 2025 at 9:22 AM
Stratipath Breast is the first CE-IVD, AI-based prognostic risk profiling tool. It analyses cancer tissue, enabling the identification of either an increased or a low risk of disease progression. It is in clinical use and validated in large-scale studies. www.stratipath.com/stratipath-b...